Sleep and blood sugar in African Americans | Melanoma | Testing oral drugs

Poor sleep linked with higher blood sugar in African Americans; genetic regions linked to melanoma; robotic screening speeds drug testing

May 5, 2020 Edition COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics. Poor sleep linked with higher blood sugar levels in African Americans African American men and women who had severe sleep apnea or other disrupted sleep patterns had higher blood sugar levels than those who slept normally. New genetic regions linked to risk of melanoma Researchers linked new regions of the genome to melanoma, the deadliest form of skin cancer, suggesting new avenues to explore for a better understanding of the disease. Robotic screening speeds testing of oral drugs A robotic system to rapidly test the absorption of drugs in the small intestine could help speed the development and testing of oral medications. Popular Stories Study suggests new coronavirus may remain on surfaces for days Novel coronavirus structure reveals targets for vaccines and treatments Microneedle coronavirus vaccine triggers immune response in mice How stress causes gray hair Number of steps per day more important than step intensity Connect with Us Facebook RSS Feed Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®      This email was sent to ymilov@gmail.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612